The company was founded in 1991 and thereafter developed the world’s first non-touch breathing movement monitor for detection of respiratory cessation (apnea) in infants, known under the trademark – Babysense.

Babysense is medically certified and is a multinational company operating in more than 30 countries worldwide. We are continuously expanding our global reach and product line to benefit millions of consumers and health institutions with cutting-edge solutions.



Our Representatives

Boaz Rosis

VP Marketing & Sales, Babysense (Hisense Ltd.)

VP Marketing & Sales

Babysense (Hisense Ltd.)

Company Solutions

When timely alerts can help save lives

Babysense is a highly sensitive non-touch baby Breathing Movement Monitor, intended for detection of respiratory cessation (apnea) in babies. It constantly monitors baby’s breathing micro movements through the mattress during sleep and gives an alert to caretakers if breathing stops or becomes irregularly slow, giving critical time to intervene. A quick response can make the difference between something minor and a critical situation.

Babysense was developed in view of the dangers that infants may face in hospitals and at homes associated with sudden infant death syndrome (commonly known as SIDS and Cot or Crib Death).

SIDS remains a significant cause of death among basically healthy infants up to one year of age.

Babysense breathing movement monitor is highly effective and has helped protecting over 1 million babies around the world. Babysense is a registered class IIb medical device, approved to the Medical Devices Directive (CE) 93/42/EEC. It is clinically tested and field proven in hospitals.

Looking For

As we are continuously expanding our global reach and product line, we are looking to explore new opportunities with potential partners, distributors, investors, institutions.